TrialClinical and translational science2025

A randomized, double-blind, placebo-controlled, multiple dose, parallel study to investigate the effects of a cathepsin S inhibitor in celiac disease.

Darren Bentley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.